JP2012092144A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092144A5
JP2012092144A5 JP2012022511A JP2012022511A JP2012092144A5 JP 2012092144 A5 JP2012092144 A5 JP 2012092144A5 JP 2012022511 A JP2012022511 A JP 2012022511A JP 2012022511 A JP2012022511 A JP 2012022511A JP 2012092144 A5 JP2012092144 A5 JP 2012092144A5
Authority
JP
Japan
Prior art keywords
cell
test substance
psgl
cells
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012022511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012092144A (ja
Filing date
Publication date
Priority claimed from US10/051,497 external-priority patent/US7744888B2/en
Application filed filed Critical
Publication of JP2012092144A publication Critical patent/JP2012092144A/ja
Publication of JP2012092144A5 publication Critical patent/JP2012092144A5/ja
Pending legal-status Critical Current

Links

JP2012022511A 2001-08-03 2012-02-03 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター Pending JP2012092144A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31019601P 2001-08-03 2001-08-03
US60/310,196 2001-08-03
US10/051,497 US7744888B2 (en) 2001-08-03 2002-01-18 Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US10/051,497 2002-01-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008058501A Division JP2008260759A (ja) 2001-08-03 2008-03-07 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター

Publications (2)

Publication Number Publication Date
JP2012092144A JP2012092144A (ja) 2012-05-17
JP2012092144A5 true JP2012092144A5 (enExample) 2013-06-06

Family

ID=26729479

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003518607A Expired - Fee Related JP4815101B2 (ja) 2001-08-03 2002-03-13 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター
JP2008058501A Abandoned JP2008260759A (ja) 2001-08-03 2008-03-07 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター
JP2012022511A Pending JP2012092144A (ja) 2001-08-03 2012-02-03 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2003518607A Expired - Fee Related JP4815101B2 (ja) 2001-08-03 2002-03-13 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター
JP2008058501A Abandoned JP2008260759A (ja) 2001-08-03 2008-03-07 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター

Country Status (19)

Country Link
US (3) US7744888B2 (enExample)
EP (2) EP1411982B1 (enExample)
JP (3) JP4815101B2 (enExample)
KR (1) KR100850731B1 (enExample)
CN (2) CN1304051C (enExample)
AT (2) ATE531734T1 (enExample)
AU (1) AU2002305041B2 (enExample)
CA (1) CA2428822C (enExample)
CY (2) CY1108701T1 (enExample)
DE (1) DE60229394D1 (enExample)
DK (2) DK1985634T3 (enExample)
ES (2) ES2316569T3 (enExample)
IL (4) IL160168A0 (enExample)
MX (1) MXPA04001047A (enExample)
NO (2) NO333456B1 (enExample)
NZ (1) NZ531199A (enExample)
PT (2) PT1411982E (enExample)
TW (1) TWI327070B (enExample)
WO (1) WO2003013603A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
EP1663290A4 (en) * 2003-09-15 2009-07-01 Abgenomics Corp MODULATORS OF P-SELECTIN GLYCOPROTEIN LIGANDS 1
US7459523B2 (en) * 2003-11-12 2008-12-02 Wisconsin Alumni Research Foundation Equine P-selectin glycoprotein ligand-1 and uses thereof
AU2012201999C1 (en) * 2004-05-10 2016-05-12 Abgenomics Cooperatief U.A. Antibodies
MY148646A (en) * 2004-05-10 2013-05-15 Abgenomics Cooperatief Ua Anti-psgl-1 antibodies
BRPI0510561A (pt) * 2004-05-11 2007-11-20 Abgenomics Corp epìtopos que induzem morte de célula t
WO2007033959A2 (en) * 2005-09-19 2007-03-29 Vib Vzw Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas
WO2007067984A2 (en) * 2005-12-09 2007-06-14 Wyeth Neutralizing antibodies against primate psgl-1 and uses therefor
AU2009246166B2 (en) * 2008-05-15 2014-09-18 Tetherex Pharmaceuticals Corporation Anti-PSGL-1 antibodies and methods of identification and use
ES2387156B1 (es) * 2010-12-01 2013-07-04 Universidad Autónoma de Madrid Uso de psgl-1 para el tratamiento de enfermedades inflamatorias y autoinmunes
EP2718325A4 (en) 2011-06-13 2015-03-11 ABGENOMICS COöPERATIEF U A ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
EP4079324A1 (en) * 2014-07-08 2022-10-26 Sanford-Burnham Medical Research Institute Psgl-1 modulators and uses thereof
WO2017120534A1 (en) 2016-01-08 2017-07-13 Bioalliance C.V. Tetravalent anti-psgl-1 antibodies and uses thereof
US20170241415A1 (en) * 2016-02-19 2017-08-24 Muzan, Inc. Sanitary check valve
KR20250159733A (ko) 2017-01-11 2025-11-11 브리스톨-마이어스 스큅 컴퍼니 Psgl-1 길항제 및 그의 용도
PE20250933A1 (es) 2017-03-14 2025-04-02 Five Prime Therapeutics Inc Anticuerpos de union a vista a ph acido
SG11202008593PA (en) 2018-03-21 2020-10-29 Five Prime Therapeutics Inc ANTIBODIES BINDING TO VISTA AT ACIDIC pH
AU2019301120A1 (en) 2018-07-11 2021-02-25 Bristol-Myers Squibb Company Antibodies binding to VISTA at acidic pH
KR20250024129A (ko) 2018-07-20 2025-02-18 피에르 파브르 메디카먼트 Vista의 수용체
CN114158275A (zh) * 2019-05-03 2022-03-08 香港大学 腹膜转移细胞的检测和分离方法
KR20220042055A (ko) * 2019-06-04 2022-04-04 베르조 테라퓨틱스, 아이엔씨. 골수성 세포 염증성 표현형을 조절하기 위한 항-psgl-1 조성물 및 방법, 그리고 이의 용도
WO2025168211A1 (en) * 2023-02-10 2025-08-14 Novo Nordisk A/S P-selectin peptide ligands

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5378464A (en) * 1989-03-08 1995-01-03 Board Of Regents Of The University Of Oklahoma Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140
US5690933A (en) * 1989-05-31 1997-11-25 Glaxo Wellcome Inc. Monoclonal antibodies for inducing tolerance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5709859A (en) * 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US6309639B1 (en) * 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US5972625A (en) * 1991-05-06 1999-10-26 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
WO1994014836A1 (en) * 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
DE69415154T2 (de) * 1993-01-25 1999-07-29 Dana-Farber Cancer Institute, Inc., Boston, Mass. Chimäre selektine erhältlich durch domänenaustauch und ihre verwendungen
WO1995014787A1 (en) * 1993-11-22 1995-06-01 Centocor, Inc. Peptide inhibitors of selecting binding
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
DE69630307T2 (de) 1995-08-03 2004-07-15 The Board Of Regents Of The University Of Oklahoma, Norman O-glycaninhibitoren von selectinvermittelten entzüngen
JPH09227410A (ja) 1996-02-21 1997-09-02 Sumitomo Pharmaceut Co Ltd 臓器移植拒絶反応の抑制剤
WO1999043353A2 (en) * 1998-02-26 1999-09-02 Boehringer Ingelheim Pharmaceuticals, Inc. Combination anti-selectin and immunosuppressant therapy
CN1342085A (zh) 1998-10-30 2002-03-27 遗传研究所有限公司 通过p－选择素配体(psgl)拮抗剂抑制细胞素t细胞的分化
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
PL366223A1 (en) 2000-12-29 2005-01-24 Bio-Technology General Corp. Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
MY148646A (en) 2004-05-10 2013-05-15 Abgenomics Cooperatief Ua Anti-psgl-1 antibodies
BRPI0510561A (pt) 2004-05-11 2007-11-20 Abgenomics Corp epìtopos que induzem morte de célula t
EP2718325A4 (en) 2011-06-13 2015-03-11 ABGENOMICS COöPERATIEF U A ANTI-PSGL-1 ANTIBODIES AND USES THEREOF

Similar Documents

Publication Publication Date Title
NZ711723A (en) Microfluidic devices and methods for use thereof in multicellular assays of secretion
MX2015012823A (es) Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo.
WO2014015194A3 (en) Methods for detecting and measuring aggregation
MX389472B (es) Inmunoensayo que utiliza un conjugado de captura
WO2019105468A8 (en) Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibody
HK1223943A1 (zh) 嵌合的靶向抗原受体的单克隆抗体
EP2801092A4 (en) METHODS, DEVICES AND COMPUTER PROGRAM PRODUCTS FOR IMPLEMENTING AUTOMATIC LANGUAGE RECOGNITION AND RECEIVING RECOGNITION ON A DEVICE
SG11201402709WA (en) Method and device for assaying an antigen present on erythrocytes or an antibody binding to an antigen present on erythrocytes
AR102517A1 (es) Ensayos para detectar subgrupos inmunes de células t y sus métodos de uso
JP2016511405A5 (enExample)
EP2972348A4 (en) METHOD FOR DETECTING DONATOR-SPECIFIC ANTIBODIES AND SYSTEMS FOR CARRYING OUT THEREOF
TR201904882T4 (tr) Tıbbi kullanım için bispesifik antikorlar.
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
EP2941121A4 (en) SYSTEM BASED ON A BIOLOGICAL SENSOR FOR THE DETECTION OF MATERIALS
PH12016501339A1 (en) Novel anti-netrin-1 antibody
JP2015520378A5 (enExample)
SG10201806729VA (en) Novel assay to detect human periostin
WO2015003160A3 (en) Hepatocytes in co-culture and uses thereof
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
IL289158A (en) Anti-cd123 antibodies, anti-cd123 chimeric antigen receptors and t cells anti-cd123 chimeric antigen receptors
WO2016077558A8 (en) Methods for blood typing and antibody screening
SG11201700407QA (en) Frame member-equipped transfer film, biomolecule analysis device, reagent tank, and shaking device
FR2996010B1 (fr) Dispositif de prediction des seismes et des eruptions volcaniques, de localisation des epicentres et des magnitudes par la mesure du radon dans le sol
WO2012158207A3 (en) Method for mutiplexed microfluidic bead-based immunoassay
WO2015069718A3 (en) Pre-haptoglobin-2 monoclonal antibodies and uses thereof